Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

A study to compare the glycemic and quality of life benefits of diabetes management using Dexcom G6 continuous glucose monitoring (CGM) or self-monitored blood glucose (SMBG) made by study participants and their primary care physicians. Decisions will be based on insights from real-time use and retrospective insights, determined during remote visits. Participants will have type 2 diabetes and be using basal insulin (with or without oral medications and/or Glucagon-Like-Peptide-1 (GLP-1) analogue) and have an elevated Hemoglobin A1C (HbA1c).

Key facts

Study ID
NCT03566693
Run by
DexCom, Inc.
People needed
176
Starts
2018-07-30
Expected to finish
2021-01-04
Last updated by the study team
2021-04-21

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.